The Glow Blend is a triple-peptide research formulation of GHK-Cu, BPC-157, and TB-500 — covering copper-peptide skin biology, localized connective tissue repair, and systemic cell-migration wound healing in one vial.
Product definition
What is Glow Blend (GHK-Cu / BPC-157 / TB-500)?
The Glow Blend is a triple-peptide research formulation of GHK-Cu, BPC-157, and TB-500 — covering copper-peptide skin biology, localized connective tissue repair, and systemic cell-migration wound healing in one vial.
The Glow Blend is a combined research formulation containing three peptides with documented independent preclinical research profiles and mechanistically non-overlapping activity patterns:
GHK-Cu (Glycyl-L-histidyl-L-lysine copper(II)) is a naturally occurring copper tripeptide complex studied for collagen and elastin synthesis stimulation, fibroblast proliferation, wound closure, hair follicle activation, and anti-inflammatory mechanisms in dermal models. Its copper co-factor activity supports lysyl oxidase function — critical for extracellular matrix structural integrity.
BPC-157 (Body Protection Compound 157) is a 15-amino-acid pentadecapeptide with the most extensive gut-barrier and tendon/ligament repair literature of any research peptide, operating through NO-system angiogenesis promotion and VEGF pathway interaction in localized injury models.
TB-500 (Thymosin Beta 4) is a 43-amino-acid actin-sequestering peptide studied across cardiac, dermal, and musculoskeletal injury models for its role in cell migration, wound closure, and inflammation modulation via actin-G/LKKTET motif interaction.
The Glow Blend's research rationale is mechanistic complementarity: three distinct molecular mechanisms, three distinct receptor/pathway targets, and three distinct primary tissue research contexts combined for coverage across the skin and tissue repair research landscape.
Research context
How is Glow Blend (GHK-Cu / BPC-157 / TB-500) described in the research literature?
GHK-Cu promotes collagen synthesis and extracellular matrix remodeling via TGF-β and fibroblast activation. BPC-157 targets localized angiogenesis and connective tissue repair through NO-system and VEGF pathways. TB-500 enables systemic cell migration and wound closure via actin-G regulation across cardiac, dermal, and musculoskeletal tissues. Three distinct, non-redundant mechanisms in one formulation.
Compound profile
Key facts about Glow Blend (GHK-Cu / BPC-157 / TB-500)
- Components
- GHK-Cu + BPC-157 + Thymosin Beta 4 (TB-500)
- GHK-Cu mechanism
- Copper peptide, collagen synthesis, TGF-β/MMP modulation
- BPC-157 mechanism
- NO-system angiogenesis, connective tissue repair
- TB-500 mechanism
- Actin-G regulation, systemic cell migration, wound closure
- Research category
- Dermal repair, skin biology, wound healing, multi-mechanism tissue research
- Format
- Lyophilized blend (single vial)
- Storage
- Lyophilized: −20°C. Reconstituted: 2–8°C, use within 30 days
Research areas
What research areas is Glow Blend (GHK-Cu / BPC-157 / TB-500) associated with?
- GHK-Cu covers copper-peptide collagen synthesis and skin aging biology — the dermal-specific research dimension
- BPC-157 adds localized connective tissue angiogenesis and wound repair — gut, tendon, and tissue-specific mechanisms
- TB-500 contributes systemic cell migration and wound closure across cardiac, dermal, musculoskeletal systems
- Three mechanistically distinct and non-redundant repair pathways — no pharmacological redundancy in the combination
- Single-vial convenience for multi-peptide dermal/tissue repair research protocols
- All three components have independent preclinical research bases across multiple published studies
Research audience
Who researches Glow Blend (GHK-Cu / BPC-157 / TB-500)?
The Glow Blend is used by researchers in dermal biology, wound healing, skin aging, connective tissue repair, and multi-pathway tissue regeneration research. It is particularly suited to investigators who need coverage across the copper-peptide collagen biology dimension, the localized angiogenesis dimension, and the systemic cell-migration repair dimension in a single compound preparation.
Preclinical research overview
What does the preclinical literature say about Glow Blend (GHK-Cu / BPC-157 / TB-500)?
The Glow Blend was formulated as a research convenience product combining three of the most studied tissue-repair peptide classes into a single preparation. The rationale for combining all three (rather than using the Wolverine Blend BPC-157+TB-500 alone) is the GHK-Cu dimension: copper-peptide biology operates through completely different molecular mechanisms (TGF-β, MMP modulation, lysyl oxidase cofactor activity) than either BPC-157's NO-system mechanism or TB-500's actin regulation mechanism.
For skin aging and dermatology-focused research, GHK-Cu is the primary mechanistic compound of interest. Adding BPC-157 and TB-500 provides coverage of wound bed angiogenesis (critical for skin wound healing) and dermal cell migration and re-epithelialization (TB-500's documented role in cutaneous wound closure). The three mechanisms converge on wound healing from distinct molecular angles.
In preclinical research terms, the Glow Blend enables single-protocol investigation of multiple peptide mechanisms simultaneously — reducing preparation complexity in studies where three separate lyophilized compounds would otherwise need to be reconstituted, dosed, and tracked independently.
Common questions
Frequently asked about Glow Blend (GHK-Cu / BPC-157 / TB-500)
How does the Glow Blend differ from the Wolverine Blend?
The Wolverine Blend contains BPC-157 and TB-500 — the two most-studied tissue repair peptides with complementary localized (BPC-157) and systemic (TB-500) repair mechanisms. The Glow Blend adds GHK-Cu to that base, adding the copper-peptide dermal biology dimension: collagen synthesis, extracellular matrix remodeling, and hair follicle research. The Glow Blend is the better choice for skin-aging and dermatology-focused research; the Wolverine Blend is the better choice for musculoskeletal and cardiac repair research without the copper-peptide dimension.
Are the three components in the Glow Blend compatible in solution?
No documented negative interactions between GHK-Cu, BPC-157, and TB-500 in combined solution have been published. The three peptides have distinct structures (tripeptide vs pentadecapeptide vs 43-AA protein), and their mechanisms are pharmacologically independent — no competitive receptor binding or mutual antagonism has been characterized in the published literature.
Which Glow Blend ratio should researchers select?
Peptific offers the Glow Blend in standard research ratios. Selection depends on the target tissue system and protocol duration. For dermal-focused research, GHK-Cu dose is often the primary variable to optimize; for wound healing protocols covering multiple tissue types, the BPC-157 and TB-500 components become more relevant in the dosing decision.
Available now
Live alternatives from this research category
These products from the same research category are currently available for ordering.
Research Use Only
Sold for laboratory and research purposes only. Not approved for, nor intended for, human or veterinary consumption, diagnostic use, or therapeutic application. These products have not been evaluated by the Food and Drug Administration. Keep out of reach of children. For use by qualified researchers only.
Nothing on this page constitutes medical advice, a treatment recommendation, or a clinical protocol. Consult a qualified healthcare provider before making any health or treatment decisions.
By accessing this product page you confirm that you are a qualified researcher aged 18 or older and that you will use this product solely for lawful laboratory research purposes. View Research Use Policy